Medicare Enrolled
Dr. Don Luong, M.D.
Hematology · Largo, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Luong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luong? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Luong
Dr. Don Luong is a hematology in Largo, FL, with 18 years in practice. Based on federal Medicare data, Dr. Luong performed 182,508 Medicare services across 4,320 unique beneficiaries.
Between the years covered by Open Payments, Dr. Luong received a total of $15,992 from 84 pharmaceutical and/or device companies across 708 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luong is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 26% volume in FL$ $15,992 industry payments
Medicare Practice Summary
Medicare Utilization ↗182,508
Medicare services
Top 26% in FL for hematology
4,320
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,139 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 76,500 | $0 | $4 |
| Iron sucrose injection (Venofer) | 18,500 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 16,000 | $43 | $137 |
| Iron infusion (Injectafer) | 15,000 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 11,260 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 11,050 | $1 | $5 |
| Filgrastim injection (Zarxio) for white blood cells | 7,620 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 5,700 | $18 | $51 |
| Immune globulin infusion (Gammagard) | 3,732 | $36 | $108 |
| Complete blood count (CBC) with differential | 3,029 | $8 | $29 |
| Blood draw (venipuncture) | 2,719 | $8 | $9 |
| Dexamethasone injection (steroid) | 2,412 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,430 | $1 | $28 |
| Office visit, established patient (30-39 min) | 1,055 | $95 | $339 |
| Office visit, established patient (20-29 min) | 812 | $64 | $239 |
| Drug injection, under skin or into muscle | 808 | $10 | $69 |
| Injection, fluorouracil, 500 mg | 538 | $2 | $7 |
| Anti-nausea injection (ondansetron/Zofran) | 500 | $0 | $9 |
| Administration of chemotherapy into vein, 1 hour or less | 407 | $96 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 365 | $22 | $84 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 358 | $47 | $189 |
| Injection of additional new drug or substance into vein | 254 | $12 | $61 |
| Injection, zoledronic acid, 1 mg | 227 | $7 | $69 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 226 | $1 | $6 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 186 | $16 | $59 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 149 | $15 | $56 |
| Injection, magnesium sulfate, per 500 mg | 148 | $1 | $2 |
| Injection, diphenhydramine hcl, up to 50 mg | 119 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 118 | $53 | $206 |
| Prothrombin time test (blood clotting) | 108 | $4 | $15 |
| Red blood count, automated test | 104 | $4 | $10 |
| New patient office visit (45-59 min) | 104 | $119 | $453 |
| Infusion into a vein for hydration, each additional hour | 99 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 93 | $21 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 92 | $48 | $178 |
| Infusion, normal saline solution , 1000 cc | 92 | $2 | $7 |
| Injection of drug or substance into vein | 86 | $28 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 70 | $3 | $11 |
| Infusion into a vein for hydration, 31-60 minutes | 64 | $24 | $156 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 61 | $24 | $89 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 61 | $124 | $637 |
| Administration of additional new drug or substance into vein using push technique | 51 | $42 | $170 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 34 | $1 | $7 |
| Office visit, established patient, complex (40-54 min) | 32 | $140 | $474 |
| Automated urinalysis | 29 | $2 | $8 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 24 | $4 | $15 |
| Drawing of blood for a medical problem | 21 | $67 | $277 |
| Red blood count automated, with additional calculations | 16 | $5 | $20 |
| Hospital follow-up visit, moderate complexity | 16 | $63 | $197 |
| New patient office visit (30-44 min) | 15 | $68 | $298 |
| Initial hospital admission, high complexity | 14 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
52.8% high complexity
42.5% medium
4.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,992
Total received (2018-2024)
Avg $2,285/year across 7 years
Top 31% in FL for hematology
84
Companies
708
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,238 (95.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$754 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,783
2023$2,953
2022$1,356
2021$713
2020$437
2019$3,707
2018$2,042
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,594
AstraZeneca Pharmaceuticals LP
$1,164
PFIZER INC.
$1,120
Celgene Corporation
$1,093
E.R. Squibb & Sons, L.L.C.
$766
Genentech USA, Inc.
$568
Lilly USA, LLC
$536
Merck Sharp & Dohme LLC
$484
GENZYME CORPORATION
$461
Janssen Biotech, Inc.
$416
Amgen Inc.
$394
Daiichi Sankyo Inc.
$356
Seagen Inc.
$348
Gilead Sciences, Inc.
$329
ABBVIE INC.
$301
Takeda Pharmaceuticals U.S.A., Inc.
$274
Incyte Corporation
$274
Stemline Therapeutics Inc.
$265
TESARO, Inc.
$259
Eisai Inc.
$257
Merck Sharp & Dohme Corporation
$235
Regeneron Healthcare Solutions, Inc.
$224
Exelixis Inc.
$222
Seattle Genetics, Inc.
$206
Astellas Pharma US Inc
$202
Blueprint Medicines Corporation
$191
Alexion Pharmaceuticals, Inc.
$187
Janssen Pharmaceuticals, Inc
$155
Karyopharm Therapeutics Inc.
$148
Kite Pharma, Inc.
$147
BeiGene USA, Inc.
$146
ARRAY BIOPHARMA INC
$144
Adaptive Biotechnologies Corporation
$138
EISAI INC.
$124
GlaxoSmithKline, LLC.
$124
Ipsen Biopharmaceuticals, Inc
$122
EMD Serono, Inc.
$119
Pharmacyclics LLC, An AbbVie Company
$114
CSL Behring
$102
Rigel Pharmaceuticals, Inc.
$102
SOBI, INC
$94
PharmaEssentia USA Corporation
$89
Intuitive Surgical, Inc.
$87
AVEO Pharmaceuticals, Inc.
$72
AbbVie, Inc.
$69
Deciphera Pharmaceuticals Inc.
$67
TAIHO ONCOLOGY, INC.
$55
Bayer HealthCare Pharmaceuticals Inc.
$55
TerSera Therapeutics LLC
$54
Spectrum Pharmaceuticals Inc.
$52
Array BioPharma Inc.
$52
Pharmacosmos Therapeutics Inc.
$51
Genmab U.S., Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$45
Kyowa Kirin, Inc.
$39
Mirati Therapeutics, Inc.
$39
Sumitomo Pharma America, Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Myriad Genetic Laboratories, Inc.
$33
Apellis Pharmaceuticals, Inc.
$31
Sun Pharmaceutical Industries Inc.
$31
Helsinn Therapeutics (U.S.), Inc.
$29
Novocure Inc.
$28
Shire North American Group Inc
$26
Jazz Pharmaceuticals Inc.
$24
Fennec Pharmaceuticals, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$24
G1 Therapeutics, Inc.
$23
Tempus AI, Inc
$23
SpringWorks Therapeutics, Inc.
$23
Taiho Oncology, Inc.
$21
Alnylam Pharmaceuticals Inc.
$19
Heron Therapeutics, Inc.
$18
MorphoSys, US Inc.
$17
CTI BioPharma Corp.
$17
R-Pharm US LLC
$17
Myovant Sciences Inc.
$16
AbbVie Inc.
$16
Aveo Pharmaceuticals, Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Puma Biotechnology, Inc.
$14
Agios Pharmaceuticals, Inc.
$11
Collegium Pharmaceutical, Inc.
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$11
Top 3 companies account for 24.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AUGTYRO · AYVAKIT · Afstyla · Alecensa · Avastin · BENLYSTA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Creon · DARZALEX · DOPTELET · Da Vinci Surgical System · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · EVENITY · EXKIVITY · Empaveli · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Idelvion · Imbruvica · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TALZENNA · TASIGNA · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XT CDX · XTANDI · Xtampza ER · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYKADIA · Zevalin · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
37
Per 100K population
3.9
County median income
$70,293
Nearest hospital
HCA FLORIDA NORTHSIDE HOSPITAL
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Luong is a mixed practice specialist, with above-average Medicare volume (top 26% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Luong experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Luong performed 76,500 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luong receive payments from pharmaceutical companies?
Yes. Dr. Luong received a total of $15,992 from 84 companies across 708 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luong's costs compare to other hematologys in Largo?
Dr. Luong's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Largo
Browse hematologys in Largo ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology